Dubai: H.H. Sheikh Ahmed bin Saeed Al Maktoum, Chairman of the Dubai Health Board of Directors, honoured the donors of the Hamdan Bin Rashid Cancer Hospital in recognition of their generosity, which is driving the construction of Dubai’s first fully integrated comprehensive cancer care facility.
According to Emirates News Agency, the ceremony, organised by Al Jalila Foundation, the philanthropic arm of Dubai Health, to honour the donors, took place at the construction site of the hospital in Dubai Healthcare City Phase 2. The event was attended by Dr. Raja Easa Al Gurg, member of the Dubai Health Board of Directors, Chairperson of the Al Jalila Foundation Board of Directors and Chair of the Hamdan Bin Rashid Cancer Hospital Steering Committee; Dr. Amer Sharif, CEO of Dubai Health, and Dr. Amer Al Zarooni, CEO of Al Jalila Foundation.
Fifty-five donors, including individuals, charitable organisations and public and private entities, were recognised at the ceremony. H.H. Sheikh Ahmed bin Saeed Al Maktoum affirmed that giving is deeply rooted in the UAE’s longstanding humanitarian legacy and remains a driving force behind both development and charitable work. He said that guided by the vision of the leadership, the UAE continues to uphold these core values, and the establishment of the Hamdan Bin Rashid Cancer Hospital reflects the principles laid down by the founding fathers.
Dr. Al Gurg emphasized the significance of the hospital, stating that it embodies the vision of the leadership, which recognizes human health as the nation’s true wealth. By establishing a fully integrated facility, the hospital aims to provide hope to patients and their families and create an advanced centre for specialised cancer care. She expressed gratitude to all partners and supporters for their invaluable contributions and trust in the mission.
Dr. Sharif highlighted that the hospital will serve as both a centre for treatment and a beacon of hope for patients, offering advanced medical capabilities that meet international standards. It will also act as a learning and research hub, contributing to the discovery of new treatments and the development of approaches that improve patient outcomes and quality of life.
Dr. Al Zarooni noted that Al Jalila Foundation is responsible for raising funds to support the construction and development of the hospital through strategic partnerships with donors. The hospital, located in Dubai Healthcare City Phase 2, will feature extensive facilities and serve as a centre of excellence for cancer treatment and research in the region.